Population pharmacokinetics and dose adjustment of cefepime/tazobactam high dose (WCK4282) in patients with intermittent haemodialysis
Latest Information Update: 28 May 2019
At a glance
- Drugs Cefepime/tazobactam (Primary)
- Indications Gram-negative infections
- Focus Pharmacokinetics
- 28 May 2019 New trial record
- 16 Apr 2019 Results assessing population pharmacokinetics and dose adjustment of cefepime/tazobactam presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases